Current issues in adolescent immunization

Vaccine

Volumn 26, Issue 33, 2008, Pages 4120-4134

  Brabin, Loretta ^a   Greenberg, David P ^b,c   Hessel, Luc ^b   Hyer, Randall ^d   Ivanoff, Bernard ^e   Van Damme, Pierre ^f  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b SANOFI PASTEUR   (France)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

^e Direction des OpérationsInternationales   (France)

^f UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Adolescent; Immunization; Vaccine

Indexed keywords

CHICKENPOX VACCINE; DIPHTHERIA VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; MENINGOCOCCUS VACCINE; PERTUSSIS VACCINE; RECOMBINANT HEPATITIS B VACCINE; RESPIRATORY SYNCYTIAL VIRUS VACCINE; TETANUS TOXOID; TYPHOID VACCINE; WART VIRUS VACCINE;

ADOLESCENT HEALTH; CHICKENPOX; DIPHTHERIA; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTH PROMOTION; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; MEASLES; MENINGITIS; MENINGOCOCCOSIS; MUMPS; PERTUSSIS; PRIORITY JOURNAL; REVIEW; RUBELLA; TETANUS; TYPHOID FEVER; VACCINATION; VIRUS INFECTION; WORLD HEALTH ORGANIZATION;

ADOLESCENT; HEALTH POLICY; HUMANS; IMMUNIZATION SCHEDULE; PAPILLOMAVIRUS VACCINES; PERTUSSIS VACCINE; PNEUMOCOCCAL VACCINES;

EID: 48949116090     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.04.055     Document Type: Review

References (95)

1. United Nations Population Fund. State of World Population Report; 2003.
2. Schaffner W., Brooks D.A., Jensen H.B., Juszczak L., and Word B.M. Adolescent vaccination. Bridging the gap from a strong childhood foundation to a healthy adulthood. A report on strategies to increase adolescent immunization rates. Natl Found Infect Dis (2005)
3. Zimmerman R.K., Middleton D.B., Burns I.T., Clover R.D., and Kimmel S.R. Routine vaccines across the life span, 2005. J Fam Pract 54 1 Suppl. (2005) S9-S26
4. From the Centers for Disease Control and Prevention. Ten great public health achievements-United States, 1900-1999. JAMA 281 16 (1999) 1481
5. Zanetti A.R., Mariano A., Romano L., D'Amelio R., Chironna M., Coppola R.C., et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 15 366(9494) (2005) 1379-1384
6. Stroffolini T. The changing pattern of hepatitis B virus infection over the past three decades in Italy. Dig Liver Dis 37 8 (2005) 622-627
7. Mele A., Mariano A., Tosti M.E., Stroffolini T., Pizzuti R., Gallo G., et al. Acute hepatitis delta virus infection in Italy: incidence and risk factors after the introduction of the universal anti-hepatitis B vaccination campaign. Clin Infect Dis 44 3 (2007) e17-e24
8. Viral Hepatitis Prevention Board. Prevention of viral hepatitis in Italy: lessons learnt and the way forward. VHPB Meeting Report, November 7-8, 2002, Catania, Italy. Viral Hepat 2003;11: 2.
9. Baggett H.C., Duchin J.S., Shelton W., Zerr D.M., Heath J., Ortega-Sanchez I.R., et al. Two nosocomial pertussis outbreaks and their associated costs-King County, Washington, 2004. Infect Control Hosp Epidemiol 28 5 (2007) 537-543
10. Davis J.P. Clinical and economic effects of pertussis outbreaks. Pediatr Infect Dis J 24 6 Suppl. (2005) S109-S116
11. Forsyth K.D., Wirsing von Konig C.H., Tan T., Caro J., and Plotkin S. Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine 25 14 (2007) 2634-2642
12. O'Brien J.A., and Caro J.J. Hospitalization for pertussis: profiles and case costs by age. BMC Infect Dis 5 (2005) 57
13. O'Brien J.A., Caro J.J., and Getsios D. Managing meningococcal disease in the United States: hospital case characteristics and costs by age. Value Health 9 4 (2006) 236-243
14. Harrison L.H., Pass M.A., Mendelsohn A.B., Egri M., Rosenstein N.E., Bustamante A., et al. Invasive meningococcal disease in adolescents and young adults. JAMA 286 6 (2001) 694-699
15. Centers for Disease Control and Prevention (CDC). Pertussis-United States, 1997-2000. MMWR Morb Mortal Wkly Rep 2002;51:73-6.
16. Girard D.Z. The cost of epidemiological transition: a study of a decrease in pertussis vaccination coverage. Health Policy 74 3 (2005) 287-303
17. Hay J.W., and Ward J.I. Economic considerations for pertussis booster vaccination in adolescents. Pediatr Infect Dis J 24 6 Suppl. (2005) S127-S133
18. Shepard C.W., Ortega-Sanchez I.R., Scott R.D., and Rosenstein N.E. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States. Pediatrics 115 5 (2005) 1220-1232
19. Tylee A., Haller D.M., Graham T., Churchill R., and Sanci L.A. Youth-friendly primary-care services: how are we doing and what more needs to be done?. Lancet 369 9572 (2007) 1565-1573
20. Oster N.V., McPhillips-Tangum C.A., Averhoff F., and Howell K. Barriers to adolescent immunization: a survey of family physicians and pediatricians. J Am Board Fam Pract 18 1 (2005) 13-19
21. Immunization of adolescents. Recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association. MMWR Recomm Rep 1996;22(45(RR-13)):1-16.
22. Lannon C., Brack V., Stuart J., Caplow M., McNeill A., Bordley W.C., et al. What mothers say about why poor children fall behind on immunizations. A summary of focus groups in North Carolina. Arch Pediatr Adolesc Med 149 10 (1995) 1070-1075
23. Klein J.D., Wilson K.M., McNulty M., Kapphahn C., and Collins K.S. Access to medical care for adolescents: results from the 1997 Commonwealth Fund Survey of the Health of Adolescent Girls. J Adolesc Health 25 2 (1999) 120-130
24. Schmitt H.J. Factors influencing vaccine uptake in Germany. Vaccine 20 Suppl. 1 (2001) S2-S4
25. Kleinert S. Adolescent health: an opportunity not to be missed. Lancet 369 9567 (2007) 1057-1058
26. World Health Organization. Preventing HIV/AIDS in young people. Evidence from developing countries that works. A summary of the WHO Technical Report Series No. 938; 2006. Available from: URL: http://www who int/child-adolescent-health/publications/ADH/ISBN_92_4_120938_0.htm [accessed March 10, 2007].
27. World Health Organization. Global strategies, policies, and practices from immunization of adolescents. A review (1999), World Health Organisation. http://www.who.int/child-adolescent-health/New_Publications/ADH/WHO_VB_9 9.24.pdf Available from: URL: http://www.who.int/child-adolescent-health/New_Publications/ADH/WHO_VB_9 9.24.pdf [accessed March 1, 2007]
28. EUVAC. Vaccination schedules. Available from: URL: http://www EUVAC net/graphics/euvac/vaccination/pertussis html [accessed March 30, 2007].
29. World Health Organization. Vaccine schedule (2007), World Health Organisation. http://www.who.int/vaccines/GlobalSummary/Immunization/ScheduleSelect.cf m Available from: URL: http://www.who.int/vaccines/GlobalSummary/Immunization/ScheduleSelect.cf m [accessed March 30, 2007]
30. World Health Organization. Vaccine introduction guidelines. Adding a vaccine to a national immunization program (2005), World Health Organisation. http://www.who.int/vaccines-documents/DocsPDF05/777_screen.pdf Available from: URL: http://www.who.int/vaccines-documents/DocsPDF05/777_screen.pdf [accessed March 5, 2007]
31. Guerra F.A. Delays in immunization have potentially serious health consequences. Paediatr Drugs 9 3 (2007) 143-148
32. Trotter C.L., and Ramsay M.E. Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines. FEMS Microbiol Rev 31 1 (2007) 101-107
33. Boostrix prescribing information. Available from: URL: http://us.gsk.com/products/assets/us_boostrix.pdf [accessed May 31, 2007].
34. Adacel prescribing information. Available from: URL: http://www.vaccineshoppe.com/US_PDF/ADACEL_2023385_11.16.06.pdf [accessed May 31, 2007].
35. Kroger A.T., Atkinson W.L., Marcuse E.K., and Pickering L.K. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 55 RR-15 (2006) 1-48
36. Bilukha O.O., and Rosenstein N. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 54 RR-7 (2005) 1-21
37. Tarkowski T.A., Koumans E.H., Sawyer M., Pierce A., Black C.M., Papp J.R., et al. Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population. J Infect Dis 189 1 (2004) 46-50
38. Revised recommendations of the Advisory Committee on Immunization Practices to Vaccinate all Persons Aged 11-18 Years with Meningococcal Conjugate Vaccine. MMWR Morb Mortal Wkly Rep; 2007;56(31):794-5.
39. Winer R.L., Lee S.K., Hughes J.P., Adam D.E., Kiviat N.B., and Koutsky L.A. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 157 3 (2003) 218-226
40. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 102 5A (1997) 3-8
41. Committee to Study Priorities for Vaccine Development, Division of Health Promotion and Disease Prevention, Institute of Medicine. Vaccines for the 21st century. A tool for decisionmaking (1999), National Academy Press, Washington, DC
42. Bearinger L.H., Sieving R.E., Ferguson J., and Sharma V. Global perspectives on the sexual and reproductive health of adolescents: patterns, prevention, and potential. Lancet 369 9568 (2007) 1220-1231
43. Kangas I., Andersen B., McGarrigle C.A., and OStergaard L. A comparison of sexual behaviour and attitudes of healthy adolescents in a Danish high school in 1982, 1996, and 2001. Popul Health Metr 2 1 (2004) 5
44. Woynarowska B., Malkowska A., and Tabak I. Sexual behaviour among adolescents aged 16- and 18-years in Poland in 2005. Ginekol Pol 77 9 (2006) 667-677
45. Orji E.O., and Esimai O.A. Sexual behaviour and contraceptive use among secondary school students in Ilesha south west Nigeria. J Obstet Gynaecol 25 3 (2005) 269-272
46. Ozer E.M., Park M.J., Paul T., Brindis C.D., and Irwin Jr. C.E. Americas adolescents. Are they healthy? (2003), National Adolescent Health Information Center. http://nahic.ucsf.edu/index.php/publications/article/americas_adolescent s_are_they_healthy Available from: URL: http://nahic.ucsf.edu/index.php/publications/article/americas_adolescent s_are_they_healthy [accessed May 31, 2007]
47. Adams S.H., Newacheck P.W., Park M.J., Brindis C.D., and Irwin Jr. C.E. Health insurance across vulnerable ages: patterns and disparities from adolescence to the early 30 s. Pediatrics 119 5 (2007) e1033-e1039
48. Neinstein L.S. Adolescent healthcare: a practical guide (2002), Lippincott, Williams, and Wilkins, Philadelphia
49. Garside R., Ayres R., Owen M., Pearson V.A., and Roizen J. Anonymity and confidentiality: rural teenagers' concerns when accessing sexual health services. J Fam Plann Reprod Health Care 28 1 (2002) 23-26
50. Alan Guttmacher Institute. Executive summary of qualitative evidence on adolescent's views of sexual and reproductive health in Sub-Saharan Africa (2005), Alan Guttmacher Institute. http://www.guttmacher.org/pubs/summaries/2005/03/30/exs16.pdf Available from: URL: http://www.guttmacher.org/pubs/summaries/2005/03/30/exs16.pdf [accessed February 28, 2007]
51. Thrall J.S., McCloskey L., Ettner S.L., Rothman E., Tighe J.E., and Emans S.J. Confidentiality and adolescents' use of providers for health information and for pelvic examinations. Arch Pediatr Adolesc Med 154 9 (2000) 885-892
52. Rosenthal S.L., Kottenhahn R.K., Biro F.M., and Succop P.A. Hepatitis B vaccine acceptance among adolescents and their parents. J Adolesc Health 17 4 (1995) 248-254
53. Keane M.T., Walter M.V., Patel B.I., Moorthy S., Stevens R.B., Bradley K.M., et al. Confidence in vaccination: a parent model. Vaccine 23 19 (2005) 2486-2493
54. Woodruff B.A., Unti L., Coyle K., and Boyer-Chuanroong L. Parents' attitudes toward school-based hepatitis B vaccination of their children. Pediatrics 98 3 Pt 1 (1996) 410-413
55. Bates A.S., Fitzgerald J.F., Dittus R.S., and Wolinsky F.D. Risk factors for underimmunization in poor urban infants. JAMA 272 14 (1994) 1105-1110
56. Zimet G.D., Kee R., Winston Y., Perkins S.M., and Maharry K. Acceptance of hepatitis B vaccination among adult patients with sexually transmitted diseases. Sex Transm Dis 28 11 (2001) 678-680
57. Brabin L., Roberts S.A., Farzaneh F., and Kitchener H.C. Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. Vaccine 24 April (16) (2006) 3087-3094
58. Davis K., Dickman E.D., Ferris D., and Dias J.K. Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis 8 3 (2004) 188-194
59. Lazcano-Ponce E., Rivera L., Arillo-Santillan E., Salmeron J., Hernandez-Avila M., and Munoz N. Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico. Arch Med Res 32 3 (2001) 243-247
60. Mays R.M., and Zimet G.D. Recommending STI vaccination to parents of adolescents: the attitudes of nurse practitioners. Sex Transm Dis 31 7 (2004) 428-432
61. Olshen E., Woods E.R., Austin S.B., Luskin M., and Bauchner H. Parental acceptance of the human papillomavirus vaccine. J Adolesc Health 37 3 (2005) 248-251
62. Zimet G.D. Improving adolescent health: focus on HPV vaccine acceptance. J Adolesc Health 37 6 Suppl. (2005) S17-23
63. Zimet G.D., Perkins S.M., Sturm L.A., Bair R.M., Juliar B.E., and Mays R.M. Predictors of STI vaccine acceptability among parents and their adolescent children. J Adolesc Health 37 3 (2005) 179-186
64. Zimet G.D., Liddon N., Rosenthal S.L., Lazcano-Ponce E., and Allen B. Chapter 24: Psychosocial aspects of vaccine acceptability. Vaccine 24 Suppl. 3 (2006) S201-S209
65. Mays R.M., Sturm L.A., and Zimet G.D. Parental perspectives on vaccinating children against sexually transmitted infections. Soc Sci Med 58 7 (2004) 1405-1413
66. Kahn J.A., Zimet G.D., Bernstein D.I., Riedesel J.M., Lan D., Huang B., et al. Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. J Adolesc Health 37 6 (2005) 502-510
67. McInerny T.K., Cull W.L., and Yudkowsky B.K. Physician reimbursement levels and adherence to American Academy of Pediatrics well-visit and immunization recommendations. Pediatrics 115 4 (2005) 833-838
68. Freed G.L., Freeman V.A., Clark S.J., Konrad T.R., and Pathman D.E. Pediatrician and family physician agreement with and adoption of universal hepatitis B immunization. J Fam Pract 42 6 (1996) 587-592
69. Loewenson P.R., White K.E., Osterholm M.T., and MacDonald K.L. Physician attitudes and practices regarding universal infant vaccination against hepatitis B infection in Minnesota: implications for public health policy. Pediatr Infect Dis J 13 5 (1994) 373-378
70. Moorthy S. Global physician and consumer perceptions of human papilloma virus (HPV) disease and attitudes towards HPV vaccination: results of multinational surveys. 23rd International Papillomavirus Conference and Clinical Workshop (2006) Abstract PS, p. 1-6
71. Streefland P.H. Introduction of a HIV vaccine in developing countries: social and cultural dimensions. Vaccine 21 13/14 (2003) 1304-1309
72. Anand S., and Barnighausen T. Health workers and vaccination coverage in developing countries: an econometric analysis. Lancet 369 9569 (2007) 1277-1285
73. Salisbury D.M. Development of immunization policy and its implementation in the United Kingdom. Health Aff (Millwood) 24 3 (2005) 744-754
74. Wilson T.R., Fishbein D.B., Ellis P.A., and Edlavitch S.A. The impact of a school entry law on adolescent immunization rates. J Adolesc Health 37 6 (2005) 511-516
75. Jacobs R.J., and Meyerhoff A.S. Effect of middle school entry requirements on hepatitis B vaccination coverage. J Adolesc Health 34 5 (2004) 420-423
76. Gupta S., Roos L.L., Walld R., Traverse D., and Dahl M. Delivering equitable care: comparing preventive services in Manitoba. Am J Public Health 93 12 (2003) 2086-2092
77. Hesketh T., and Zhu W.X. The one child family policy: the good, the bad, and the ugly. BMJ 314 7095 (1997) 1685-1687
78. Hotchkiss D.R., Eisele T.P., Djibuti M., Silvestre E.A., and Rukhadze N. Health system barriers to strengthening vaccine-preventable disease surveillance and response in the context of decentralization: evidence from Georgia. BMC Public Health 6 (2006) 175
79. Soeung S., Grundy J., Biggs B., Boreland M., Cane J., Samnang C., et al. Management systems response to improving immunization coverage in developing countries: a case study from Cambodia. Rural Remote Health 4 2 (2004) 263
80. Brabin L., Roberts S.A., and Kitchener H.C. A semi-qualitative study of attitudes to vaccinating adolescents against human papillomavirus without parental consent. BMC Public Health 7 (2007) 20
81. Hessel L. Risk management, vaccines, and vaccination. Screening 4 (2005) 18-20
82. Daley M.F., Liddon N., Crane L.A., Beaty B.L., Barrow J., Babbel C., et al. A national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination. Pediatrics 118 6 (2006) 2280-2289
83. Raley J.C., Followwill K.A., Zimet G.D., and Ault K.A. Gynecologists' attitudes regarding human papilloma virus vaccination: a survey of Fellows of the American College of Obstetricians and Gynecologists. Infect Dis Obstet Gynecol 12 3/4 (2004) 127-133
84. Riedesel J.M., Rosenthal S.L., Zimet G.D., Bernstein D.I., Huang B., Lan D., et al. Attitudes about human papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol 18 6 (2005) 391-398
85. Alderman E.M., Lauby J.L., and Coupey S.M. Problem behaviors in inner-city adolescents with chronic illness. J Dev Behav Pediatr 16 5 (1995) 339-344
86. Villa L.L. Prophylactic HPV vaccines: reducing the burden of HPV-related diseases. Vaccine 24 Suppl. 1 (2006) S23-S28
87. United Nations. UN Millenium Development Goals; 2005. Available at: URL: http://www.un.org/milleniumgoals [accessed July 10].
88. Centers for Disease Control and Prevention (CDC), Division of STD Prevention. Genital HPV infection-CDC fact sheet. Available at: URL: http://www.cdc.gov/std/HPV/STDFact-HPV.htm [accessed November 15, 2007].
89. Mosher W.D., Chandra A., and Jones J. Sexual behavior and selected health measures: men and women 15-44 years of age, United States, 2002. Adv Data 362 (2005) 1-55
90. Gissmann L., Wolnik L., Ikenberg H., Koldovsky U., Schnurch H.G., and Hausen H.Z. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. PNAS 80 2 (1983) 560-563
91. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans, volume 90, human papillomaviruses vol. 90 (2005), IARC, Lyon, France
92. World Health Organization. WHO vaccine-preventable diseases: monitoring system 2006 global summary (2006), World Health Organisation. http://www.who.int/vaccines-documents/GlobalSummary/GlobalSummary.pdf Available from: URL: http://www.who.int/vaccines-documents/GlobalSummary/GlobalSummary.pdf [accessed March 1, 2007]
93. Crump J.A., Luby S.P., and Mintz E.D. The global burden of typhoid fever. Bull World Health Organ 82 5 (2004) 346-353
94. Recombivax HB product features. Merck vaccines; 2006. Available from: URL: www.merckvaccines.com [accessed March 1, 2007].
95. Ferlay J., Bray F., Pisani P., Parkin D.M., and International Agency for Research on Cancer (IARC). GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide (2004), IARC Press, Lyon, France